It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2019.
2019 | Hyderabad, Telangana, India | ActiveCrescent Therapeutics Private Limited, a active private limited company, was established on 25 December 2019 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24100TG2019PTC137919. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Formerly known as Jrs Formulations Private Limited. Employing 1 professional, Its leadership includes Javeed Shaik (Director), Shaik Junaid (Director), Shaik Janimiya (Managing Director). Past directors included Sita Kambham, Rajamouli Janagam. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Crescent Towers, 4-7-11/4/B,First Floor Raghavendra Nagar, Nacharam, Hyderabad, Telangana, 500076.
U24100TG2019PTC137919
137919
25 December 2019
₹1.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Crescent Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Javeed Shaik | Director | 25 Dec 2019 | Current |
| Shaik Junaid | Director | 18 Jan 2021 | Current |
| Shaik Janimiya | Managing Director | 25 Dec 2019 | Current |
| Shaik Thahera | Director | 25 Dec 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Nov 2024 | Past |
| Pramod Abcsdd | Director | 08 Dec 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Crescent Therapeutics Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2022, Crescent Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Crescent Therapeutics has a workforce of 1 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Crescent Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crescent Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Crescent Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Crescent Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Shaik Junaid was appointed as a Director was appointed as a Director on 18 Jan 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.
The activity Javeed Shaik was appointed as a Director was appointed as a Director on 25 Dec 2019 & has been associated with this company since 5 years 11 months . was completed.
The activity Shaik Janimiya was appointed as a Managing Director was appointed as a Managing Director on 25 Dec 2019 & has been associated with this company since 5 years 11 months . was completed.
Progress on Shaik Thahera was appointed as a Director was appointed as a Director on 25 Dec 2019 & has been associated with this company since 5 years 11 months . was documented.
The CIN of Crescent Therapeutics Private Limited is U24100TG2019PTC137919.
Crescent Therapeutics Private Limited is headquartered at Crescent Towers, 4-7-11/4/B,First Floor Raghavendra Nagar, Nacharam, Hyderabad, Telangana, 500076.
Crescent Therapeutics Private Limited was incorporated on 25 December 2019.
The current directors of Crescent Therapeutics Private Limited are
The primary industry of Crescent Therapeutics Private Limited is Pharma.
Crescent Therapeutics Private Limited is unlisted.
The authorized capital of Crescent Therapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX